CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Head & Neck Cancers
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Oncology Nursing News
Precision Medicine in Oncology
Special Reports in Personalized Cancer Care
SELECT A TOPIC
Attend An Event
State of the Science Summit
Regional Seminar Series
OS by PS in Metastatic Pancreatic Cancer Treatment- Data From an Exploratory Subgroup Analysis
<< View More Conferences
2018 SGO Winter Meeting
Oncology Conference Multimedia
View more videos >>
Dr. Backes on Pelvic Exenteration Surgery in Gynecologic Cancer
Dr. Arend on the Rationale of Novel Combinations in Gynecologic Cancer
Dr. West on Quality of Life Challenges in Gynecologic Cancer
Oncology Conference Articles
Immunotherapy Combos on Horizon for Ovarian Cancer
Several phase III studies are exploring immunotherapy combinations with the potential to disrupt the systemic treatment paradigm for patients with ovarian cancer.
PARP Combinations Offer New Opportunities in Ovarian Cancer
PARP inhibitor combination regimens have the potential to enhance the relatively modest benefit offered by several monotherapy approaches used for the treatment of patients with ovarian cancer.
PARP Combos With Bevacizumab, Immunotherapy in Development for Ovarian Cancer Treatment
Rebecca C. Arend, MD, discussed novel combinations being investigated for the treatment of patients with ovarian cancer.
Expert Highlights PARP Inhibitor Advancements in Ovarian Cancer, Points to Future Combos
David O'Malley, MD, discusses the excitement surrounding PARP inhibitors for patients with ovarian cancer.
Immune Checkpoint Combinations Show Promise in Endometrioid Disease
Many endometrioid cancers express high RNA levels for multiple immune checkpoints, and this may allow physicians to treat these patients with combination immune therapies.
Adjuvant Therapy Does Not Improve Survival for Early Stage Uterine Leiomyosarcoma
Adjuvant therapy, regardless of the treatment modality, did not improve overall survival compared with observation for women with early stage, uterine-confined leiomyosarcoma.
Robotic Radiosurgery May Provide New Option for Recurrent Gynecologic Cancers
The administration of stereotactic body radiation therapy through the use of CyberKnife therapy appears to be a safe and effective salvage treatment for women with previously irradiated, locally recurrent gynecologic cancer.
Immunotherapy Combinations Slated to Pave the Way in Ovarian Cancer Treatment
Kathleen Moore, MD, discusses combination strategies with immunotherapy for patients with ovarian cancer.
Study Highlights Impact of Race, Geography on Genetic Variation in Endometrial Cancer
An analysis of black women of Caribbean descent with type I or type II endometrial cancer showed that this population expressed significant differences in genetic variations compared with a nationwide population of patients with endometrial cancer.
FDA Approval in HCC, Breakthrough Designation in MCL, and More
Dabrafenib/Trametinib Combo Induces High Responses in BRAF V600E-Mutant Biliary Tract Cancer
Treatment Goals in Refractory mCRC
FDA Approves Third Trastuzumab Biosimilar
Olaratumab Falls Short in Phase III Soft Tissue Sarcoma Trial
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
American Journal of Managed Care
Oncology Nursing News
Physicians' Education Resource
Physician's Money Digest
Specialty Pharmacy Times
Terms & Conditions
2 Clarke Drive
Cranbury, NJ 08512
Copyright OncLive 2006-2018
Intellisphere, LLC. All Rights Reserved.